These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22195812)
1. Glia/ischemia tissue dual specific gene expression vector for glioblastoma gene therapy. Kim HA; Park JH; Cho SH; Lee J; Lee M J Control Release; 2011 Nov; 152 Suppl 1():e146-8. PubMed ID: 22195812 [No Abstract] [Full Text] [Related]
2. Suicidal gene therapy against tumor using reducible poly (oligo-D-arginine). Kim KM; Won YW; Adhikary PP; Hwang YM; Kim YH J Control Release; 2011 Nov; 152 Suppl 1():e148-9. PubMed ID: 22195813 [No Abstract] [Full Text] [Related]
3. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma. Jang SJ; Kang JH; Kim KI; Lee TS; Lee YJ; Lee KC; Woo KS; Chung WS; Kwon HC; Ryu CJ; Choi TH; Choi CW; Lim SM; Cheon GJ Cancer Lett; 2010 Nov; 297(1):84-90. PubMed ID: 20819721 [TBL] [Abstract][Full Text] [Related]
4. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model. Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer. Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003 [TBL] [Abstract][Full Text] [Related]
6. Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells. Ishiwata N; Inase N; Fujie T; Tamaoka M; Yoshizawa Y Anticancer Res; 2003; 23(2B):1405-9. PubMed ID: 12820402 [TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
8. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin. Greco O; Powell TM; Marples B; Joiner MC; Scott SD Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381 [TBL] [Abstract][Full Text] [Related]
10. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene. Pastorakova A; Hlubinova K; Jakubikova J; Altaner C Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529 [TBL] [Abstract][Full Text] [Related]
11. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy. Kim HA; Park JH; Yi N; Lee M Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192 [TBL] [Abstract][Full Text] [Related]
12. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy. Izquierdo M; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Cortés ML; Paz JF; Isla A; Blázquez MG Gene Ther; 1996 Jun; 3(6):491-5. PubMed ID: 8789798 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. Palù G; Cavaggioni A; Calvi P; Franchin E; Pizzato M; Boschetto R; Parolin C; Chilosi M; Ferrini S; Zanusso A; Colombo F Gene Ther; 1999 Mar; 6(3):330-7. PubMed ID: 10435083 [TBL] [Abstract][Full Text] [Related]
14. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Boviatsis EJ; Park JS; Sena-Esteves M; Kramm CM; Chase M; Efird JT; Wei MX; Breakefield XO; Chiocca EA Cancer Res; 1994 Nov; 54(22):5745-51. PubMed ID: 7954393 [TBL] [Abstract][Full Text] [Related]
15. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model. Oh B; Han J; Choi E; Tan X; Lee M J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673 [TBL] [Abstract][Full Text] [Related]
16. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Izquierdo M; Cortés M; de Felipe P; Martín V; Díez-Guerra J; Talavera A; Perez-Higueras A Gene Ther; 1995 Jan; 2(1):66-9. PubMed ID: 7712334 [TBL] [Abstract][Full Text] [Related]
17. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene]. Quillien V; Heresbach Le Berre N; Dufour T; Denais A; Guegan Y; Ferry N; Bloin V Bull Cancer; 1997 Nov; 84(11):1047-52. PubMed ID: 9536986 [TBL] [Abstract][Full Text] [Related]
18. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481 [TBL] [Abstract][Full Text] [Related]
20. [Using the thymidine kinase gene in therapy of solid tumors]. Wicke I; Gansbacher B Internist (Berl); 1996 Apr; 37(4):369-73. PubMed ID: 8655273 [No Abstract] [Full Text] [Related] [Next] [New Search]